Abstract The 2019 Coronavirus Pandemic challenges the delivery of care for patients with
head and neck cancer. An important aspect of this care has been the evolution of enhanced
survivorship services, which include surveillance for recurring cancer and prevention of
second primaries. The application of evidence‐based approaches to the identification and
management of treatment and tumor‐related toxicities has embraced the use of validated
patient‐reported outcomes instruments, health promotion, and care coordination. In this …

The 2019 Coronavirus Panademic challenges the delivery of care for patients with head and
neck cancer. An important aspect of this care has been the evolution of enhanced
survivorship services which include surveillance for recurring cancer and prevention of
second primaries. The application of evidence based approaches to identification and
management of treatment and tumor related toxicities has embraced the use of validated
patient reported outcomes instruments (PROs), health promotion, and care coordination. In …